UBS Group’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.85M | Buy |
1,745,717
+108,531
| +7% | +$550K | ﹤0.01% | 2517 |
|
|
2025
Q1 | $4.94M | Buy |
1,637,186
+1,407,610
| +613% | +$4.25M | ﹤0.01% | 2962 |
|
|
2024
Q4 | $831K | Buy |
+229,576
| New | +$831K | ﹤0.01% | 4349 |
|
|
2024
Q2 | – | Sell |
-20,192
| Closed | -$39.4K | – | 8880 |
|
|
2024
Q1 | $39.4K | Buy |
20,192
+3,766
| +23% | +$7.34K | ﹤0.01% | 5453 |
|
|
2023
Q4 | $23.2K | Buy |
16,426
+12,027
| +273% | +$17K | ﹤0.01% | 5809 |
|
|
2023
Q3 | $6.95K | Buy |
+4,399
| New | +$6.95K | ﹤0.01% | 6120 |
|
|
2023
Q2 | – | Sell |
-1,000
| Closed | -$2.1K | – | 8523 |
|
|
2023
Q1 | $2.1K | Buy |
+1,000
| New | +$2.1K | ﹤0.01% | 7482 |
|
|
2022
Q4 | – | Sell |
-5,975
| Closed | -$18K | – | 9876 |
|
|
2022
Q3 | $18K | Buy |
5,975
+3,975
| +199% | +$12K | ﹤0.01% | 6452 |
|
|
2022
Q2 | $6K | Sell |
2,000
-2,000
| -50% | -$6K | ﹤0.01% | 7698 |
|
|
2022
Q1 | $21K | Buy |
4,000
+2,868
| +253% | +$15.1K | ﹤0.01% | 6369 |
|
|
2021
Q4 | $8K | Buy |
+1,132
| New | +$8K | ﹤0.01% | 7945 |
|
|
2021
Q3 | – | Sell |
-3,164
| Closed | -$15K | – | 8851 |
|
|
2021
Q2 | $15K | Buy |
+3,164
| New | +$15K | ﹤0.01% | 6557 |
|
|
2020
Q4 | – | Sell |
-1,637
| Closed | -$5K | – | 7688 |
|
|
2020
Q3 | $5K | Sell |
1,637
-38,412
| -96% | -$117K | ﹤0.01% | 6460 |
|
|
2020
Q2 | $178K | Buy |
40,049
+2,050
| +5% | +$9.11K | ﹤0.01% | 4087 |
|
|
2020
Q1 | $106K | Buy |
37,999
+34,551
| +1,002% | +$96.4K | ﹤0.01% | 4392 |
|
|
2019
Q4 | $14K | Buy |
+3,448
| New | +$14K | ﹤0.01% | 6033 |
|
|
2019
Q3 | – | Sell |
-1,931
| Closed | -$10K | – | 7198 |
|
|
2019
Q2 | $10K | Buy |
+1,931
| New | +$10K | ﹤0.01% | 6207 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7170 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7253 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7207 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7192 |
|
|
2018
Q1 | – | Sell |
-261
| Closed | -$13K | – | 7095 |
|
|
2017
Q4 | $13K | Sell |
261
-191
| -42% | -$9.51K | ﹤0.01% | 5904 |
|
|
2017
Q3 | $32K | Buy |
+452
| New | +$32K | ﹤0.01% | 5222 |
|
|
2017
Q2 | – | Sell |
-7
| Closed | – | – | 6890 |
|
|
2017
Q1 | $0 | Sell |
7
-106
| -94% | – | ﹤0.01% | 6856 |
|
|
2016
Q4 | $3K | Sell |
113
-1,347
| -92% | -$35.8K | ﹤0.01% | 6450 |
|
|
2016
Q3 | $65K | Sell |
1,460
-423
| -22% | -$18.8K | ﹤0.01% | 4442 |
|
|
2016
Q2 | $74K | Buy |
1,883
+509
| +37% | +$20K | ﹤0.01% | 4398 |
|
|
2016
Q1 | $76K | Sell |
1,374
-200
| -13% | -$11.1K | ﹤0.01% | 4407 |
|
|
2015
Q4 | $216K | Buy |
1,574
+438
| +39% | +$60.1K | ﹤0.01% | 3717 |
|
|
2015
Q3 | $163K | Buy |
1,136
+368
| +48% | +$52.8K | ﹤0.01% | 3849 |
|
|
2015
Q2 | $199K | Buy |
+768
| New | +$199K | ﹤0.01% | 3878 |
|